RE: [Critical Care Nutrition] Digest for criticalcarenutrition@googlegroups.com - 1 update in 1 topic

[MacEachern, Judy]

The reality is ICU patients are getting the soybean lipid source from propofol. It has little to do with the Dietitian’s adjustments of TPN (if used).

 

Judy MacEachern RD CDE

Clinical Dietitian

ICU, Surgery, Paediatrics, Paediatric Diabetes Program

Guelph General Hospital

 

From: criticalca...@googlegroups.com [mailto:criticalca...@googlegroups.com]
Sent: January-12-17 12:03 AM
To: Digest recipients
Subject: [Critical Care Nutrition] Digest for criticalca...@googlegroups.com - 1 update in 1 topic

 

criticalca...@googlegroups.com

Google Groups

Topic digest
View all topics

·         fungemia and parenteral nutrition - 1 Update

fungemia and parenteral nutrition

"Drover, Dr. John W." <dro...@KGH.KARI.NET>: Jan 12 04:08AM Dear Hilda, I am not aware of guidelines specific to fungemia. The best we might do is look at the data that is available on the use of IV lipids in critically ill patients. This is relatively weak evidence but is a recommendation that can be found here: http://www.criticalcarenutrition.com/docs/CPGs%202015/9.2%202015.pdf   As you will note it comes with our weakest recommendation that a strategy that reduces the load of omega-6 fatty acids/soy bean oils should be considered.   On the practical side I would usually recommend not using soy based IV lipid emulsions in the first week of illness associated with bacteremia/fungemia/sepsis and then introduce lipids. We are then more commonly using another source of lipids rather than Intralipid but if that is not available would start with low dose Intralipid such as thrice weekly.   I hope this helps. Cheers     John W. Drover, MD, FRCSC, FACS, CCPE Professor Departments of Critical Care Medicine and Surgery Queen’s University Critical Care Physician Lead, South East LHIN Kingston General Hospital   Davies 2 76 Stuart Street Kingston, Ontario Canada K7L 2V7 Phone 613-549-6666 ext 6336 Fax 613-548-1325<tel:613-548-1325>     The information contained in this electronic message and any attachments to this message are intended for the exclusive use of the addressee(s) and may contain confidential or privileged information. If the reader of this message is not the intended recipient, or the agent responsible to deliver it to the intended recipient, you are hereby notified that any review, retransmission, dissemination or other use of this communication is prohibited. If you received this in error, please contact the sender and destroy all copies of this e-mail.   From: criticalca...@googlegroups.com [mailto:criticalca...@googlegroups.com] On Behalf Of HildaSeyler Sent: Saturday, January 07, 2017 6:30 AM To: Critical Care Nutrition Subject: [Critical Care Nutrition] fungemia and parenteral nutrition   Can anyone direct me to any guidelines / best practice recommendations regarding the use of parenteral nutrition for patients who have fungemia? Our pharmacist tells me that they had an education session where material was presented that indicated to stop IV lipids, but could continue with amino acid/dextrose infusion.   -- You received this message because you are subscribed to the Google Groups "Critical Care Nutrition" group. To unsubscribe from this group and stop receiving emails from it, send an email to criticalcarenutr...@googlegroups.com<mailto:criticalcarenutr...@googlegroups.com>. To post to this group, send email to criticalca...@googlegroups.com<mailto:criticalca...@googlegroups.com>. Visit this group at https://groups.google.com/group/criticalcarenutrition. For more options, visit https://groups.google.com/d/optout.

Back to top

You received this digest because you're subscribed to updates for this group. You can change your settings on the group membership page. To unsubscribe from this group and stop receiving emails from it send an email to criticalcarenutr...@googlegroups.com.

 

--------------------------------------------------------------------------------
CONFIDENTIALITY NOTICE: This message, including any attachments, is intended only for the use of the intended recipient(s) and may contain information that is privileged, confidential and prohibited from unauthorized disclosure under applicable law. This material may be subject to the provisions of the Freedom of Information and Protection of Privacy Act or the Personal Health Information Protection Act. If you are not the intended recipient or have received this message in error, please notify us immediately by reply e-mail and permanently delete original transmission. Thank you.  ­­